Emerging Clinical Trial HUBs IN EECCA

UNFOLD CT XChange seeks to address the urgent need for greater patient diversity in clinical research, driven by the rapid global expansion of clinical trials. Through a thought-provoking series of panel discussions, the initiative will spotlight emerging hubs in EECCA (Eastern Europe, Caucasus, and Central Asia), with a particular focus onGeorgia, Ukraine, Armenia, and Uzbekistan.

‍

Our inaugural webinar will explore the significant opportunities these regions present, such as access to diverse patient populations, skilled investigators, and cost-effective operations. At the same time, we will tackle the unique challenges they pose, from regulatory hurdles to geopolitical instability and logistical complexities.

‍

Featuring panel discussions led by regulators and industry experts from leading pharmaceutical companies, biotechnology firms, and global CROs, the event will critically examine the advantages and disadvantages of conducting clinical trials in these emerging hubs. Together, we will address the pivotal question: Are these challenges genuine risks, or can they be transformed into opportunities with the right strategies?

webinar highlights

Explore harnessing opportunities to accelerate research timelines with expedited trial initiation and patient enrollment due to streamlined regulations; optimize trial costs with reduced operational expenses; expand patient diversity with access to unique populations; and ensure high-quality data with the expertise of experienced investigators in emerging clinical trial hubs.

Gain valuable insights into managing potential challenges in emerging clinical trial hubs, including regulatory and logistical complexities due to varying standards, limited infrastructure affecting data quality and patient safety, adherence to international ethical standards, and addressing language and cultural barriers in communication and recruitment.

Uncover best practices in emerging clinical trial hubs by assessing regulatory and ethical standards, collaborating with experienced local CROs, preparing for political and economic challenges with contingency planning, securing insurance for supply chain disruptions, ensuring quality through audits, addressing cultural barriers with effective communication, maintaining ethical oversight, and accounting for population diversity to improve study relevance.

Emerging Clinical Trial HUBs IN EECCA

webinar highlights

who should attend ?